What the Study Found (In Plain English)
Published in Lasers in medical science (2025), this meta-analysis evaluating human clinical outcomes investigated: Topical minoxidil is currently a standard treatment for androgenic alopecia (AGA). Key clinical takeaway: Regarding safety, no difference in the adverse events (AEs) was observed between two groups. This study suggests superior efficacy of combination LLLT and topical minoxidil over topical minoxidil alone for the management of AGA with comparable safety profile.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Lasers in medical science, 2025-08-19; Meta-Analysis; Rigor 86/100): Regarding safety, no difference in the adverse events (AEs) was observed between two groups. This study suggests superior efficacy of combination LLLT and topical minoxidil over topical minoxidil alone for the management of AGA with comparable safety profile.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.